A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib
Clinical trial NCT05451316 · COMPLETED
Trial details
- NCT number
- NCT05451316
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-08
- Primary completion
- 2024-11-02
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.